Poland· PL-100411131
Treosulfan Zentiva
A treosulfan product containing treosulfanum, registered in Poland by TILLOMED MALTA LTD.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Treosulfan is registered in 16 of 19 countries.
Countries holding a registration under ATC L01AB02 (treosulfan), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Treosulfan · ATC L01AB02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Treosulfanum
- Manufacturer
- TILLOMED MALTA LTD.
- Country
- Poland (PL)
- ATC code
- L01AB02
- ATC class
- Treosulfan
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991398859
- gtin05909991398866
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Treosulfan in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTRECONDIMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
- SpainTRECONDI 5 G POLVO PARA SOLUCION PARA PERFUSIONMedac Gesellschaft Für Klinische Spezialpräparate Gmbh
- FinlandTrecondiMedac Gesellschaft Für Klinische Spezialpräparate mbH
- BelgiumTrecondi 5 gMedac
- SwedenTrecondi 5 g Pulver till infusionsvätska, lösningmedac Gesellschaft für klinische Spezialpräparate mbH
- IcelandTrecondimedac Gesellschaft für klinische Spezialpräparate GmbH
- NorwayTrecondiMedac - Gesellschaft für klinische Spezialpräparate Gmbh - Wedel
- IrelandTreosulfan Tillomed 5 g powder for solution for infusionLaboratorios Tillomed Spain, S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Treosulfan Tillomed
- Belgium · Treosulfan Tillomed
- Czechia · Treosulfan Tillomed
- Germany · Ovastat, Treosulfan Tillomed
- Denmark · Treosulfan Tillomed
- Spain · Treosulfano Zentiva
- Finland · Treosulfan Tillomed
- France · Treosulfan Tillomed
- United Kingdom (Northern Ireland) · Treosulfan Tillomed Laboratories
- Greece · Treosulfan Tillomed
- Ireland · Treosulfan Tillomed
- Iceland · Trecondi
- Liechtenstein · Trecondi
- Netherlands · Treosulfan Tillomed
- Norway · Trecondi, Treosulfan Tillomed
- Portugal · Treossulfano Tillomed
- Romania · Treosulfan Tillomed
- Sweden · Treosulfan Tillomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e7375e93-0454-4e64-9dd7-e93827053c40 GET /v1/drugs/e7375e93-0454-4e64-9dd7-e93827053c40?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "5 g",
"packaging": "05909991398859 ¦ Rp ¦ 132086\n1 fiol. 5 g proszku\n05909991398866 ¦ Rp ¦ 132087\n5 fiol. 5 g proszku",
"substance": "Treosulfan 5 g",
"common_name": "Treosulfanum",
"pl_product_id": "100411131",
"pozwolenie_nr": "25232",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about treosulfan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.